Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Stock Has Average Price Target of $30.69 According to Analysts

Key Points

• Analyst sentiment is mixed: Acadia Healthcare has an average “Hold” rating from 15 analysts, with a consensus 12-month price target of $30.69 versus the stock’s $29.23 opening price.
• Institutional interest has increased: BlackRock, Jefferies Financial Group and Deutsche Bank each established sizable positions, while Invenomic Capital Management raised its stake by 71%.
• Recent results beat expectations: Acadia reported quarterly EPS of $0.38 versus the $0.35 consensus and revenue of $865.84 million, above estimates, though revenue declined 0.4% year over year and the company posted a negative net margin.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) have been assigned an average recommendation of "Hold" from the fifteen ratings firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $30.69.

Several equities analysts have recently commented on the company. Cantor Fitzgerald restated a "neutral" rating on shares of Acadia Healthcare in a research report on Tuesday. KeyCorp increased their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a research report on Tuesday, July 14th. Barclays lifted their target price on Acadia Healthcare from $25.00 to $32.00 and gave the stock an "equal weight" rating in a report on Thursday, July 30th. Raymond James Financial cut shares of Acadia Healthcare from a "strong-buy" rating to an "outperform" rating and set a $39.00 price target for the company. in a research note on Monday, September 28th. Finally, Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a report on Wednesday, September 9th.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. bought a new position in Acadia Healthcare during the 2nd quarter worth about $441,685,000. Jefferies Financial Group Inc. acquired a new stake in shares of Acadia Healthcare during the second quarter worth $106,458,000. Deutsche Bank AG purchased a new stake in Acadia Healthcare during the 2nd quarter valued at about $49,746,000. Invenomic Capital Management LP boosted its position in Acadia Healthcare by 71.0% in the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company's stock valued at $46,998,000 after buying an additional 1,375,647 shares during the last quarter. Finally, Vaughan Nelson Investment Management L.P. purchased a new stake in shares of Acadia Healthcare in the 1st quarter valued at $43,017,000.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $29.23 on Thursday. Acadia Healthcare has a one year low of $11.43 and a one year high of $35.83. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a market cap of $2.72 billion, a P/E ratio of -2.35, a P/E/G ratio of 9.35 and a beta of 0.63. The stock's fifty day moving average is $28.94 and its 200 day moving average is $27.61.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm's quarterly revenue was down .4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Sell-side analysts anticipate that Acadia Healthcare will post 1.55 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a provider of behavioral healthcare services. The company operates a network of psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics that provide care for individuals with mental health conditions, substance use disorders and other behavioral health needs.

Acadia's services are designed for children, adolescents and adults and may include inpatient psychiatric treatment, addiction treatment, residential care, partial hospitalization and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.